Martek Biosciences Corp v Cargill International Trading Pte Ltd
Jurisdiction | Singapore |
Court | Court of Three Judges (Singapore) |
Judge | Chao Hick Tin JA |
Judgment Date | 28 December 2010 |
Neutral Citation | [2010] SGCA 51 |
Citation | [2010] SGCA 51 |
Published date | 10 January 2011 |
Date | 28 December 2010 |
Defendant Counsel | Daniel Koh (briefed) (Eldan Law LLP) and Low Wei Ling Wendy (Rajah & Tann LLP) |
Docket Number | Civil Appeal No 55 of 2010 |
Plaintiff Counsel | Lai Tze Chang Stanley SC, Vignesh Vaerhn and Lim Ming Hui Eunice (Allen & Gledhill LLP) |
Subject Matter | Civil Procedure |
Hearing Date | 20 August 2010 |
This appeal concerns an application by the appellant for leave to adduce further evidence in relation to a pending action in the High Court challenging the decision of the Deputy Registrar of Patents and the Principal Assistant Registrar of Patents (hereafter referred to collectively as “the Tribunal”) to revoke the appellant’s Singapore patent P-No 42669 (“the Patent”). The appellant’s application (“the Interlocutory Application”) was refused by the High Court judge (“the Judge”), which led the appellant to file the present appeal against the Judge’s decision.
Background The Patent pertains to a method for producing arachidonic acid (“ARA”) in triglyceride form for use in infant formula. One of the claims of the Patent is that “the oil [made using the patented method] comprises
At this juncture, we ought to explain that D4a is a patent in Japan relating to a skin cosmetic product which also uses ARA. The Experiment purports to set out how to make oil with all the features of the Patent’s claim. Particularly, it is claimed that the oil made from the Experiment comprises 72.9% ARA (for convenience, this claim will hereafter be referred to as “the D4a Claim”), which matches the claim in the Patent that the oil made using the patented method comprises at least 50% ARA. The Tribunal made certain findings on the invalidity of the Patent relying on,
On 19 March 2010, the appellant’s solicitors wrote in to the Judge stating that the appellant had informed them, right after the hearing of the Interlocutory Application on 12 March 2010, that it had already conducted the Experiment and that the results showed that the oil produced from the Experiment had an ARA content of less than 50% and not 72.9% as stated in the D4a Claim. The appellant’s solicitors requested for leave to make further arguments in order to persuade the Judge to reconsider the Interlocutory Application. The Judge declined the request, culminating in the present appeal by the appellant.
The decision below In the High Court GD, the Judge made the following findings:
The legal question which we have to decide in this appeal is: what is the test to be applied in deciding whether to grant leave for further evidence to be adduced pursuant to O 87A r 13(2) of the ROC in an appeal from the Patents Registrar to the High Court? As the Judge noted at [11] of the High Court GD, this question has hitherto never been decided in Singapore as the HC Appeal is the first case involving an application for leave to adduce further evidence in an appeal under O 87A r 13.
The applicable provision in the ROC is O 87A r 13(2), which provides that:
In the court below, both the parties as well as the Judge, in determining what test should be appliedAn appeal [under O 87A r 13] shall be by way of rehearing and the evidence used on appeal shall be the same as that used before the [Patents] Registrar and, except with the leave of the Court, no further evidence shall be given.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To continue reading
Request your trial-
Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd
...unworthy inventions and products from monopolising the market” (Martek Biosciences Corp v Cargill International Trading Pte Ltd [2011] 1 SLR 1287 at [37]). Such an approach would also “take into account the public interest which is injured when invalid claims are persisted in so that invent......
-
Anan Group (Singapore) Pte Ltd v VTB Bank (Public Joint Stock Co)
...to the applicability of Ladd v Marshall is that of patent disputes. In Martek Biosciences Corp v Cargill International Trading Pte Ltd [2011] 1 SLR 1287 this court noted the differences between O 57 r 13(2) and O 87A r 13(2) of the ROC, which concerned appeals under the Patents Act (Cap 221......
-
Yitai (Shanghai) Plastic Company, Ltd v Charlotte Pipe and Foundry Company
...[2000] RPC 321 (folld) Ladd v Marshall [1954] 1 WLR 1489 (folld) Martek Biosciences Corp v Cargill International Trading Pte Ltd [2011] 1 SLR 1287 (folld) Norris v Government of the United States of America [2008] 1 AC 920 (folld) PP v Mohd Ariffan bin Mohd Hassan [2018] 1 SLR 544 (folld) W......
-
Singapore Medical Council v Ang Peng Tiam
...should be applied strictly to an appeal under O 55 of the ROC. In Martek Biosciences Corp v Cargill International Trading Pte Ltd [2011] 1 SLR 1287 (“Martek”), an appeal under O 87A of the ROC against a decision of Registrar of Patents revoking a patent, the Court of Appeal held that: the 3......